Drug name - Izba

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9144561 NOVARTIS Pharmaceutical compositions having desirable bioavailability Mar, 2029

(6 years from now)

US8754123 NOVARTIS Pharmaceutical compositions having desirable bioavailability May, 2029

(6 years from now)

US8178582 NOVARTIS Pharmaceutical compositions having desirable bioavailability Oct, 2029

(7 years from now)

US8722735 NOVARTIS Pharmaceutical compositions having desirable bioavailability Oct, 2029

(7 years from now)

Drugs and Companies using TRAVOPROST ingredient

Treatment: NA

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.003% SOLUTION/DROPS;OPHTHALMIC Discontinued

availability in other generic markets.

Click on the highlighted region to filter.